What is Tofacitinib?

Category: Prescription Drugs

Most popular types: Xeljanz Xeljanz XR

false

Tofacitinib is an oral medication that is known as a disease modifying antirheumatic drug. It is used in the treatment of adult patients with moderately- to severely-active rheumatoid arthritis who are unable to take or who have had an inadequate response to methotrexate.

Reported purpose & perceived effectiveness
Purpose Patients Evaluations Perceived Effectiveness
Rheumatoid arthritis 42 15
Pain 2 1
Stiffness in morning 2 0
Alopecia areata 1 1
Arthritis pain 1 1
Headaches 1 2

Show all 7 reasons taken


  • Major
  • Moderate
  • Slight
  • None
  • Can't tell

Side effects

Side effects as an overall problem

Side effects as an overall problem
Severity Evaluations
Severe 3
Moderate 0
Mild 5
None 10

Commonly reported side effects and conditions associated with Tofacitinib

Side effect Patients
Headaches 2
High cholesterol (hypercholesterolemia) 2
Dizziness 1
Fatigue 1
Hair loss 1
Heart palpitations 1

Show all 11 reported side effects

Dosages

Based on patients currently taking Tofacitinib

Dosage Patients
5 mg twice daily 15
11 mg daily 10
5 mg daily 3
10 mg twice daily 2
1 tablet(s) twice daily 1
10 mg daily 1
20 mg daily 1

Why patients stopped taking Tofacitinib

Multiple reasons could be selected

Reason Patients
Did not seem to work 6
Doctor's advice 3
Side effects too severe 3
Other 1
See all 10 patients who've stopped taking Tofacitinib

Duration

Currently taking Tofacitinib

Duration Patients
1 - 6 months 5
6 months - 1 year 5
1 - 2 years 7
2 - 5 years 10
5 - 10 years 3

Stopped taking Tofacitinib

Duration Patients
Less than 1 month 7
1 - 6 months 2
1 - 2 years 1
Adherence
Adherence Evaluations
Always 14
Usually 3
Sometimes 0
Never taken as prescribed 1
Burden
Burden Evaluations
Very hard to take 0
Somewhat hard to take 0
A little hard to take 1
Not at all hard to take 17
Cost per month
Cost per month Evaluations
$200+ 2
$100-199 0
$50-99 1
$25-49 0
< $25 13
Not specified 2

What people switch to and from

Patients started taking Tofacitinib after stopping:

Treatment Patients
Adalimumab (Humira) 7
Methotrexate (Apo-Methotrexate) 7
Abatacept (Orencia) 4
Etanercept (Enbrel SureClick) 4
Hydroxychloroquine (Plaquenil) 4

Show all 14 treatments patients report switching from

Patients stopped taking Tofacitinib and switched to:

Treatment Patients
Adalimumab (Humira) 3
Etanercept (Enbrel SureClick) 1
Infliximab (Remicade) 1
Minocycline (Minocin) 1
Pregabalin (Lyrica) 1

Show all 8 treatments patients report switching to

Last updated:
There are no evaluations for Tofacitinib.